Misty Breakfield
Medical · Covington, LANPI 1508854993
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 261 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,970, 3.3 times the $597 reported in 2023.
Across 261 payments — averaging $17.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$681
- AbbVie$612
- Pfizer$538
- Lilly USA, LLC$423
- Amgen$283
- AstraZeneca$228
- plus $2K from 23 others
What the payments were for
- Food & beverage$4,518100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 41 | $681 |
| AbbVie | 39 | $612 |
| Pfizer | 31 | $538 |
| Lilly USA, LLC | 29 | $423 |
| Amgen | 19 | $283 |
| AstraZeneca(2 entities) | 8 | $228 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $202 |
| Tolmar, Inc. | 10 | $178 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $177 |
| IBSA Pharma Inc. | 8 | $152 |
| Paratek Pharmaceuticals, Inc. | 8 | $139 |
| Exact Sciences | 5 | $99 |
| Sumitomo Pharma America, Inc. | 4 | $85 |
| GSK | 4 | $85 |
| Idorsia Pharmaceuticals US Inc | 4 | $69 |
| Intra-sana Laboratories | 4 | $69 |
| Boehringer Ingelheim | 4 | $64 |
| Antares Pharma, Inc. | 2 | $62 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $61 |
| Currax Pharmaceuticals LLC | 3 | $48 |
| Esperion Therapeutics, Inc. | 2 | $47 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Acella Pharmaceuticals, LLC | 2 | $38 |
| Amneal Pharmaceuticals LLC | 2 | $35 |
| Novartis | 2 | $29 |
| Johnson & Johnson | 1 | $20 |
| Bayer | 1 | $19 |
| Sanofi | 1 | $19 |
| Avion Pharmaceuticals | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$120
How this compares
$4,518 in reported general payments places this provider in the 85th percentile of 253 medical providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Quetiapine Fumarate | 12 | $143 |
| Amlodipine Besylate | 12 | $39 |
Paid to pharmacies, not to this prescriber.
Other medical in Covington
- Sydney FussellCovington$16K
- Courtney CoyleCovington$6K
- Brice WagnerCovington$4K
- Kristi RobertBaton Rouge$486K
- Vickie RiceBaton Rouge$19K
- Mary McFerrenShreveport$16K
- Rachel RhinehartJefferson$16K
- Thomas BriscoeLafayette$13K
- Seth HendrixShreveport$12K
- Jessica PelusoNatchitoches$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.